You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
華潤醫藥(03320.HK)旗下華潤生物完成6億元B輪融資
阿思達克 01-10 16:48
華潤醫藥(03320.HK)公布,旗下華潤生物醫藥於日前已完成由國調基金領投的B輪融資,引入混改基金、建信股權、粵科基金、無錫國聯,涉及金額6億元,所得資金將主要用於加速創新生物藥的研究、臨床試驗階段研發管線的推進,以及外部項目的引進等。 華潤生物總經理殷惠軍表示,B輪融資得到多家投資機構的信任與支持,相信有助集團深化混合所有制改革工作,未來將通過構建原創技術策源地提升核心能力,打造長效、高效、優效的創新技術平台,加強自研與對外合作等戰略舉措,推動在研產品早日上市。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account